VVOS / Vivos Therapeutics, Inc. (VVOS) CEO Kirk Huntsman on Q4 2021 Results - Earnings Call Transcript

Vivos Therapeutics (NASDAQ:VVOS) has announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common shares effec more_horizontal

Vivos Therapeutics (NASDAQ:VVOS) announced it has signed a United States-wide distribution agreement for its oral appliances with Lincare, a leading more_horizontal

Better sleep is better health, period. But for many people, it's not that easy. more_horizontal

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Vivos Therapeutics, Inc. (VVOS) co more_horizontal

Vivos Therapeutics (NASDAQ:VVOS) Inc has announced that its flagship daytime-nighttime appliance (DNA) will be tested in a clinical trial at Stanford more_horizontal

Vivos Therapeutics (NASDAQ:VVOS) shares continued to make gains on Thursday morning after the developer of oral appilances for the treatment of sleep more_horizontal

Vivos Therapeutics (NASDAQ:VVOS) has announced two strategic agreements that will expand its current product line of oral appliances for the treatment more_horizontal

Vivos Therapeutics (NASDAQ:VVOS) said it will welcome best-selling author James Nestor to headline its Fifth Annual Breathing Wellness Conference. Nes more_horizontal